Matthew S. Milak

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial

Michael F. Grunebaum, Hanga Galfalvy, Tse‐Hwei Choo et al. · American Journal of Psychiatry · 2017 · 410 citations · Full text

Neuroanatomic Correlates of Psychopathologic Components of Major Depressive Disorder

Matthew S. Milak, Ramin V. Parsey, John G. Keilp et al. · Archives of General Psychiatry · 2005 · 177 citations

Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam‐controlled randomized clinical trial

Michael F. Grunebaum, Steven P. Ellis, John G. Keilp et al. · Bipolar Disorders · 2017 · 168 citations

Higher Serotonin 1A Binding in a Second Major Depression Cohort: Modeling and Reference Region Considerations

Ramin V. Parsey, R. Todd Ogden, Jeffrey M. Miller et al. · Biological Psychiatry · 2010 · 166 citations · Full text

Higher Serotonin 1A, Reference Region Considerations, Psychiatry +13

A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder

Matthew S. Milak, Carol J. Proper, Stephanie Mulhern et al. · Molecular Psychiatry · 2015 · 138 citations · Full text

Psychiatry, Medicine, Psychotropic Medication +13